Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
36.13
+0.06 (0.17%)
Oct 6, 2025, 4:00 PM EDT - Market closed
Royalty Pharma Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$44.50
Upside
+23.17%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +16.25% | Sep 30, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $40 → $42 | Strong Buy | Maintains | $40 → $42 | +16.25% | Jul 22, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $51 → $54 | Buy | Maintains | $51 → $54 | +49.46% | Jul 10, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $60 → $40 | Strong Buy | Maintains | $60 → $40 | +10.71% | Oct 25, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $50 → $51 | Strong Buy | Maintains | $50 → $51 | +41.16% | Aug 14, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $48 → $51 | Buy | Maintains | $48 → $51 | +41.16% | Jul 11, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades $28 | Strong Buy → Hold | Downgrades | $28 | -22.50% | Jun 3, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $40 → $38 | Strong Buy | Maintains | $40 → $38 | +5.18% | Apr 12, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $45 → $42 | Buy | Maintains | $45 → $42 | +16.25% | Feb 20, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $56 → $50 | Strong Buy | Maintains | $56 → $50 | +38.39% | Feb 20, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $54 → $57 | Buy | Maintains | $54 → $57 | +57.76% | Nov 9, 2023 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $53 → $54 | Buy | Maintains | $53 → $54 | +49.46% | Oct 11, 2023 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $52 → $53 | Buy | Maintains | $52 → $53 | +46.69% | Aug 9, 2023 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $52 | Buy | Reiterates | $52 | +43.92% | Jul 11, 2023 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $50 → $52 | Buy | Maintains | $50 → $52 | +43.92% | May 10, 2023 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $48 → $50 | Buy | Maintains | $48 → $50 | +38.39% | Apr 10, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.